Eric Easom - Oct 20, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Stock symbol
ANTX
Transactions as of
Oct 20, 2022
Transactions value $
-$349,912
Form type
4
Date filed
10/24/2022, 09:44 PM
Previous filing
May 16, 2022
Next filing
Oct 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$121K -7.26K -27.77% $16.68 18.9K Oct 20, 2022 Direct F1
transaction ANTX Common Stock Sale -$532 -31 -0.16% $17.15 18.9K Oct 20, 2022 Direct F1
transaction ANTX Common Stock Sale -$189K -11.6K -61.52% $16.29 7.26K Oct 21, 2022 Direct F1
transaction ANTX Common Stock Sale -$39.2K -2.35K -32.38% $16.69 4.91K Oct 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.